Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Thorax logoLink to Thorax
editorial
. 1995 Oct;50(10):1023–1026. doi: 10.1136/thx.50.10.1023

Inflammatory predictors for the development of the adult respiratory distress syndrome.

P T Reid, S C Donnelly, C Haslett
PMCID: PMC475011  PMID: 7491546

Full text

PDF
1023

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedrossian C. W., Woo J., Miller W. C., Cannon D. C. Decreased angiotensin-converting enzyme in the adult respiratory distress syndrome. Am J Clin Pathol. 1978 Aug;70(2):244–247. doi: 10.1093/ajcp/70.2.244. [DOI] [PubMed] [Google Scholar]
  2. Bernard G. R., Luce J. M., Sprung C. L., Rinaldo J. E., Tate R. M., Sibbald W. J., Kariman K., Higgins S., Bradley R., Metz C. A. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987 Dec 17;317(25):1565–1570. doi: 10.1056/NEJM198712173172504. [DOI] [PubMed] [Google Scholar]
  3. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest. 1987 Dec;92(6):1032–1036. doi: 10.1378/chest.92.6.1032. [DOI] [PubMed] [Google Scholar]
  4. Bone R. C., Slotman G., Maunder R., Silverman H., Hyers T. M., Kerstein M. D., Ursprung J. J. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group. Chest. 1989 Jul;96(1):114–119. doi: 10.1378/chest.96.1.114. [DOI] [PubMed] [Google Scholar]
  5. Braude S., Baudouin S., Evans T. W. Serial assessment of pulmonary microvascular permeability in a patient developing the adult respiratory distress syndrome. Eur Respir J. 1992 Apr;5(4):500–502. [PubMed] [Google Scholar]
  6. Butcher E. C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991 Dec 20;67(6):1033–1036. doi: 10.1016/0092-8674(91)90279-8. [DOI] [PubMed] [Google Scholar]
  7. Casey L., Krieger B., Kohler J., Rice C., Oparil S., Szidon P. Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report. Crit Care Med. 1981 Sep;9(9):651–654. doi: 10.1097/00003246-198109000-00008. [DOI] [PubMed] [Google Scholar]
  8. Donnelly S. C., Haslett C. Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome. Thorax. 1992 Apr;47(4):260–263. doi: 10.1136/thx.47.4.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Donnelly S. C., Haslett C., Dransfield I., Robertson C. E., Carter D. C., Ross J. A., Grant I. S., Tedder T. F. Role of selectins in development of adult respiratory distress syndrome. Lancet. 1994 Jul 23;344(8917):215–219. doi: 10.1016/s0140-6736(94)92995-5. [DOI] [PubMed] [Google Scholar]
  10. Donnelly S. C., MacGregor I., Zamani A., Gordon M. W., Robertson C. E., Steedman D. J., Little K., Haslett C. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995 May;151(5):1428–1433. doi: 10.1164/ajrccm.151.5.7735596. [DOI] [PubMed] [Google Scholar]
  11. Duchateau J., Haas M., Schreyen H., Radoux L., Sprangers I., Noel F. X., Braun M., Lamy M. Complement activation in patients at risk of developing the adult respiratory distress syndrome. Am Rev Respir Dis. 1984 Dec;130(6):1058–1064. doi: 10.1164/arrd.1984.130.6.1058. [DOI] [PubMed] [Google Scholar]
  12. Fourrier F., Chopin C., Wallaert B., Wattre P., Mangalaboyi J., Durocher A., Dubois D., Wattel F. Angiotensin-converting enzyme in human adult respiratory distress syndrome. Chest. 1983 Apr;83(4):593–597. doi: 10.1378/chest.83.4.593. [DOI] [PubMed] [Google Scholar]
  13. Fowler A. A., Hamman R. F., Good J. T., Benson K. N., Baird M., Eberle D. J., Petty T. L., Hyers T. M. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983 May;98(5 Pt 1):593–597. doi: 10.7326/0003-4819-98-5-593. [DOI] [PubMed] [Google Scholar]
  14. Fukuda Y., Ishizaki M., Masuda Y., Kimura G., Kawanami O., Masugi Y. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol. 1987 Jan;126(1):171–182. [PMC free article] [PubMed] [Google Scholar]
  15. Granert C., Raud J., Xie X., Lindquist L., Lindbom L. Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit. J Clin Invest. 1994 Mar;93(3):929–936. doi: 10.1172/JCI117098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hunter D. N., Morgan C. J., Evans T. W. The use of radionuclide techniques in the assessment of alveolar-capillary membrane permeability on the intensive care unit. Intensive Care Med. 1990;16(6):363–371. doi: 10.1007/BF01735173. [DOI] [PubMed] [Google Scholar]
  17. Ishii H., Uchiyama H., Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost. 1991 May 6;65(5):618–623. [PubMed] [Google Scholar]
  18. Kunkel S. L., Standiford T., Kasahara K., Strieter R. M. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res. 1991 Jan-Feb;17(1):17–23. doi: 10.3109/01902149109063278. [DOI] [PubMed] [Google Scholar]
  19. Lawrence M. B., Springer T. A. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991 May 31;65(5):859–873. doi: 10.1016/0092-8674(91)90393-d. [DOI] [PubMed] [Google Scholar]
  20. Macnaughton P. D., Evans T. W. Management of adult respiratory distress syndrome. Lancet. 1992 Feb 22;339(8791):469–472. doi: 10.1016/0140-6736(92)91068-j. [DOI] [PubMed] [Google Scholar]
  21. Montravers P., Gauzit R., Dombret M. C., Blanchet F., Desmonts J. M. Cardiopulmonary effects of bronchoalveolar lavage in critically ill patients. Chest. 1993 Nov;104(5):1541–1547. doi: 10.1378/chest.104.5.1541. [DOI] [PubMed] [Google Scholar]
  22. Moss M., Ackerson L., Gillespie M. K., Moore F. A., Moore E. E., Parsons P. E. von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995 Jan;151(1):15–20. doi: 10.1164/ajrccm.151.1.7812545. [DOI] [PubMed] [Google Scholar]
  23. Mulligan M. S., Miyasaka M., Tamatani T., Jones M. L., Ward P. A. Requirements for L-selectin in neutrophil-mediated lung injury in rats. J Immunol. 1994 Jan 15;152(2):832–840. [PubMed] [Google Scholar]
  24. Parsons P. E., Fowler A. A., Hyers T. M., Henson P. M. Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome. Am Rev Respir Dis. 1985 Sep;132(3):490–493. doi: 10.1164/arrd.1985.132.3.490. [DOI] [PubMed] [Google Scholar]
  25. Parsons P. E., Moore F. A., Moore E. E., Iklé D. N., Henson P. M., Worthen G. S. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis. 1992 Sep;146(3):694–700. doi: 10.1164/ajrccm/146.3.694. [DOI] [PubMed] [Google Scholar]
  26. Rubin D. B., Wiener-Kronish J. P., Murray J. F., Green D. R., Turner J., Luce J. M., Montgomery A. B., Marks J. D., Matthay M. A. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest. 1990 Aug;86(2):474–480. doi: 10.1172/JCI114733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schleiffenbaum B., Spertini O., Tedder T. F. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol. 1992 Oct;119(1):229–238. doi: 10.1083/jcb.119.1.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sekido N., Mukaida N., Harada A., Nakanishi I., Watanabe Y., Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 1993 Oct 14;365(6447):654–657. doi: 10.1038/365654a0. [DOI] [PubMed] [Google Scholar]
  29. Siler T. M., Swierkosz J. E., Hyers T. M., Fowler A. A., Webster R. O. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp Lung Res. 1989 Dec;15(6):881–894. doi: 10.3109/01902148909069633. [DOI] [PubMed] [Google Scholar]
  30. Smith C. W., Rothlein R., Hughes B. J., Mariscalco M. M., Rudloff H. E., Schmalstieg F. C., Anderson D. C. Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest. 1988 Nov;82(5):1746–1756. doi: 10.1172/JCI113788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Spertini O., Luscinskas F. W., Kansas G. S., Munro J. M., Griffin J. D., Gimbrone M. A., Jr, Tedder T. F. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol. 1991 Oct 15;147(8):2565–2573. [PubMed] [Google Scholar]
  32. Staub N. C., Hyde R. W., Crandall E. NHLBI workshop summary. Workshop on techniques to evaluate lung alveolar-microvascular injury. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):1071–1077. doi: 10.1164/ajrccm/141.4_Pt_1.1071. [DOI] [PubMed] [Google Scholar]
  33. Steinberg K. P., Mitchell D. R., Maunder R. J., Milberg J. A., Whitcomb M. E., Hudson L. D. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am Rev Respir Dis. 1993 Sep;148(3):556–561. doi: 10.1164/ajrccm/148.3.556. [DOI] [PubMed] [Google Scholar]
  34. Sturm J. A., Wisner D. H., Oestern H. J., Kant C. J., Tscherne H., Creutzig H. Increased lung capillary permeability after trauma: a prospective clinical study. J Trauma. 1986 May;26(5):409–418. doi: 10.1097/00005373-198605000-00001. [DOI] [PubMed] [Google Scholar]
  35. Takano S., Kimura S., Ohdama S., Aoki N. Plasma thrombomodulin in health and diseases. Blood. 1990 Nov 15;76(10):2024–2029. [PubMed] [Google Scholar]
  36. Tomashefski J. F., Jr Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med. 1990 Dec;11(4):593–619. [PubMed] [Google Scholar]
  37. Yu M., Tomasa G. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med. 1993 Nov;21(11):1635–1642. doi: 10.1097/00003246-199311000-00010. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES